Published in J Biol Chem on September 15, 2000
NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest (2004) 5.06
Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res (2009) 3.66
Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol (2003) 2.14
Altered TAB1:I kappaB kinase interaction promotes transforming growth factor beta-mediated nuclear factor-kappaB activation during breast cancer progression. Cancer Res (2008) 1.47
The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers. Proc Natl Acad Sci U S A (2001) 1.44
Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali. Am J Pathol (2005) 1.27
Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6. Mol Cell Biol (2004) 1.15
Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site. Biochem J (2004) 1.15
Mechanisms balancing skeletal matrix synthesis and degradation. Biochem J (2002) 1.12
Pin1 promotes transforming growth factor-beta-induced migration and invasion. J Biol Chem (2009) 1.10
Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy. Exp Biol Med (Maywood) (2010) 1.08
Global gene expression in neuroendocrine tumors from patients with the MEN1 syndrome. Mol Cancer (2005) 1.05
Dynamic evolution of immune system regulators: the history of the interferon regulatory factor family. Mol Biol Evol (2009) 1.00
X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression. J Biol Chem (2009) 0.98
Transforming growth factor beta/Smad3 signaling regulates IRF-7 function and transcriptional activation of the beta interferon promoter. Mol Cell Biol (2004) 0.93
XIAP gene expression and function is regulated by autocrine and paracrine TGF-beta signaling. Mol Cancer (2010) 0.91
Histone 3 lysine 9 (H3K9) methyltransferase recruitment to the interleukin-2 (IL-2) promoter is a mechanism of suppression of IL-2 transcription by the transforming growth factor-β-Smad pathway. J Biol Chem (2011) 0.88
The TGFβ1 pathway is required for NFκB dependent gene expression in mouse keratinocytes. Cytokine (2013) 0.80
Prolonged NF-κB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells. Infect Immun (2013) 0.79
Hypoxia-Inducible Histone Lysine Demethylases: Impact on the Aging Process and Age-Related Diseases. Aging Dis (2016) 0.77
Flow-dependent Smad2 phosphorylation and TGIF nuclear localization in human aortic endothelial cells. Am J Physiol Heart Circ Physiol (2011) 0.77
Chromatin loop organization of the junb locus in mouse dendritic cells. Nucleic Acids Res (2013) 0.76
NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells. Oncotarget (2016) 0.75
Mechanism of activation of the TGF-beta receptor. Nature (1994) 8.10
A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur J Biochem (1982) 6.74
Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell (1993) 3.51
Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol (1995) 2.80
Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. Mol Cell Biol (1994) 2.59
Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. EMBO J (1998) 2.34
Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol (1994) 2.16
Hormonal control of fructose 2,6-bisphosphate concentration in isolated rat hepatocytes. Biochem J (1983) 1.64
PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem Sci (2001) 1.43
Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology (2001) 1.43
The HERC proteins: functional and evolutionary insights. Cell Mol Life Sci (2005) 1.39
Characterization of human hect domain family members and their interaction with UbcH5 and UbcH7. J Biol Chem (1998) 1.36
The stimulation of yeast phosphofructokinase by fructose 2,6-bisphosphate. FEBS Lett (1982) 1.27
Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection. Clin Exp Immunol (2007) 1.24
Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment. Water Res (2008) 1.20
HIV seroprevalence and risk behaviors in psychiatric inpatients. Psychiatry Res (1991) 1.18
A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells. FEBS Lett (1999) 1.17
Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol Gastrointest Liver Physiol (2000) 1.15
Cells overexpressing fructose-2,6-bisphosphatase showed enhanced pentose phosphate pathway flux and resistance to oxidative stress. FEBS Lett (2000) 1.13
c-met mRNA overexpression in human hepatocellular carcinoma. Hepatology (1994) 1.11
JunB is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2. J Biol Chem (1998) 1.11
The ability of adenosine to decrease the concentration of fructose 2,6-bisphosphate in isolated hepatocytes. A cyclic AMP-mediated effect. Biochem J (1984) 1.09
Insulin-like effects of vanadate on glucokinase activity and fructose 2,6-bisphosphate levels in the liver of diabetic rats. J Biol Chem (1988) 1.05
Monitoring of pesticides in drinking and related waters in NE Spain with a multiresidue SPE-GC-MS method including an estimation of the uncertainty of the analytical results. J Chromatogr A (2001) 1.02
PFKFB3 gene silencing decreases glycolysis, induces cell-cycle delay and inhibits anchorage-independent growth in HeLa cells. FEBS Lett (2006) 1.01
Induction of the Sry-related factor SOX6 contributes to bone morphogenetic protein-2-induced chondroblastic differentiation of C3H10T1/2 cells. Mol Endocrinol (2003) 0.99
Purification and characterization of phosphoglycerate mutase isozymes from pig heart. Biochim Biophys Acta (1982) 0.99
Cell-mediated immune responses to mycobacterial antigens in patients with pulmonary tuberculosis and HIV infection. Clin Exp Immunol (1997) 0.98
Phylogeny and ontogeny of the phosphoglycerate mutases--IV. Distribution of glycerate-2,3-P2 dependent and independent phosphoglycerate mutases in algae, fungi, plants and animals. Comp Biochem Physiol B (1982) 0.94
Matrix metalloproteinase 2 in reduced-size liver transplantation: beyond the matrix. Am J Transplant (2010) 0.93
The mechanism by which ethanol decreases the concentration of fructose 2,6-bisphosphate in the liver. Biochem J (1984) 0.92
Abnormal alpha-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease. Neurobiol Dis (2004) 0.91
Inhibition of phosphoglucomutase by fructose 2,6-bisphosphate. Biochim Biophys Acta (1985) 0.90
Effect of protein kinase A activity on the association of ADP-ribosylation factor 1 to golgi membranes. J Biol Chem (2000) 0.88
Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice. J Neuropathol Exp Neurol (2004) 0.88
Bone morphogenetic protein-2 promotes dissociated effects on the number and differentiation of cultured ventral mesencephalic dopaminergic neurons. J Neurobiol (1999) 0.88
Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion. Free Radic Res (2000) 0.88
Effect of vanadate on phosphoryl transfer enzymes involved in glucose metabolism. Biochem Biophys Res Commun (1981) 0.88
How ischaemic preconditioning protects small liver grafts. J Pathol (2006) 0.87
Methotrexate for refractory Hailey-Hailey disease. J Eur Acad Dermatol Venereol (2009) 0.87
Transcriptional and posttranscriptional regulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase during liver regeneration. Proc Natl Acad Sci U S A (1992) 0.87
Effects of fructose 2,6-bisphosphate on phosphoglucomutase from plants. Plant Physiol (1986) 0.87
Vanadate inhibits 2,3-bisphosphoglycerate dependent phosphoglycerate mutases but does not affect the 2,3-bisphosphoglycerate independent phosphoglycerate mutases. Biochem Biophys Res Commun (1980) 0.87
The human ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene (PFKFB3): promoter characterization and genomic structure. Gene (2001) 0.86
Factors influencing the high content of brominated trihalomethanes in Barcelona's water supply (Spain). Bull Environ Contam Toxicol (1985) 0.86
Molecular cloning, expression, and chromosomal localization of a ubiquitously expressed human 6-phosphofructo-2-kinase/ fructose-2, 6-bisphosphatase gene (PFKFB3). Cytogenet Cell Genet (1998) 0.85
Overexpression of fructose 2,6-bisphosphatase decreases glycolysis and delays cell cycle progression. Am J Physiol Cell Physiol (2000) 0.85
HERC3 binding to and regulation by ubiquitin. FEBS Lett (2001) 0.85
Gene expression of regulatory enzymes of glycolysis/gluconeogenesis in regenerating rat liver. Biochem J (1992) 0.85
Repression of SOX6 transcriptional activity by SUMO modification. FEBS Lett (2006) 0.84
Multiresidue determination of pesticides in drinking and related waters by gas chromatography/mass spectrometry after solid-phase extraction: interlaboratory study. J AOAC Int (2001) 0.83
Spinal epidural hematoma following coronary thrombolysis. A case report. J Neurosurg Sci (2004) 0.83
The impairment of respiration by glycolysis in the Lewis lung carcinoma. Cancer Lett (1990) 0.83
Development of a solid-phase microextraction GC-NPD procedure for the determination of free volatile amines in wastewater and sewage-polluted waters. Anal Chem (1999) 0.83
Low nanogram per liter determination of halogenated nonylphenols, nonylphenol carboxylates, and their non-halogenated precursors in water and sludge by liquid chromatography electrospray tandem mass spectrometry. J Am Soc Mass Spectrom (2003) 0.82
Levels of glycerate 2,3-P2, 2,3-bisphosphoglycerate synthase and 2,3-bisphosphoglycerate phosphatase activities in rat tissues. A method to quantify blood contamination of tissue extracts. Comp Biochem Physiol B (1987) 0.82
Bovine brain 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Evidence for a neural-specific isozyme. J Biol Chem (1992) 0.82
Fructose 2,6-bisphosphate and 6-phosphofructo-2-kinase during liver regeneration. Biochem J (1990) 0.82
Pancreas transcription factor 1alpha expression is regulated in pancreatitis. Eur J Clin Invest (2007) 0.81
Exposure of foetal mesencephalic cells to bone morphogenetic protein-2 enhances the survival of dopaminergic neurones in rat striatal grafts. Neurosci Lett (1999) 0.81
Protective effect of fructose 1,6-bisphosphate against carrageenan-induced inflammation. Eur J Pharmacol (1993) 0.81
Fructose 2,6-bisphosphate and glucose 1,6-bisphosphate in erythrocytes during chicken development. FEBS Lett (1986) 0.81
Solid-phase microextraction for the determination of iodinated trihalomethanes in drinking water. J Chromatogr A (1999) 0.80
Role of fructose 2,6-bisphosphate in the control by glucagon of gluconeogenesis from various precursors in isolated rat hepatocytes. Biochem J (1984) 0.80
Effect of vanadate on the formation and stability of the phosphoenzyme forms of 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase and of phosphoglucomutase. Biochim Biophys Acta (1982) 0.80
Theoretical analysis of the flux control properties of a substrate cycle. Eur J Biochem (1986) 0.79
Evaluation of renographic and metabolic parameters in human kidney transplantation. Q J Nucl Med (1997) 0.79
Gene expression of enzymes regulating ketogenesis and fatty acid metabolism in regenerating rat liver. Biochem J (1994) 0.79
Cloning, expression and chromosomal localization of a human testis 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene. Gene (1999) 0.79
6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase expression in rat brain during development. Brain Res Mol Brain Res (2000) 0.79
Single-stranded DNA condensed with poly-L-lysine results in nanometric particles that are significantly smaller, more stable in physiological ionic strength fluids and afford higher efficiency of gene delivery than their double-stranded counterparts. Biochim Biophys Acta (2002) 0.79
Effect of galactosamine on hepatic carbohydrate metabolism: protective role of fructose 1,6-bisphosphate. Hepatology (1992) 0.78
Cerebrospinal monoamine metabolites and amino acid content in patients with parkinsonian syndrome and rats lesioned with MPP+. J Neural Transm Park Dis Dement Sect (1994) 0.78
Environmental analysis of polychlorinated terphenyls: distribution in shellfish from the Ebro Delta (Mediterranean). J Chromatogr (1993) 0.78
Behavior of halogenated disinfection by-products in the water treatment plant of Barcelona, Spain. Bull Environ Contam Toxicol (1999) 0.78
Protective effect of nifedipine against carrageenan-induced inflammation. Pharmacology (1998) 0.78
Characterization of paint samples used in drinking water reservoirs: identification of endocrine disruptor compounds. J Chromatogr Sci (2002) 0.78